Gå ubegrenset med Magzter GOLD
Få ubegrenset tilgang til over 9000 magasiner, aviser og premiumhistorier for bare
Prøve GULL - Gratis
DGCI accelerates reporting timeline for adverse effects
Mint Mumbai
|November 23, 2024
Come 1 Feb, India to enforce stricter drug safety rules, mandating 15-day reporting window
India's drug regulator has drastically advanced timelines and tightened the guidelines for reporting harmful effects of experimental drugs and treatments in efforts to improve oversight of the country's pharmaceutical industry.
The companies authorized to market medicines must report any serious adverse effects caused by a drug or treatment—such as death, disability, or a life-threatening condition—within 15 calendar days of receiving such information.
Other harmful reactions to an investigational drug or a pharmaceutical product must be reported within 90 calendar days, according to the latest pharmacovigilance guidance document released by the Drugs Controller General of India (DCGI). Mint has seen a copy of the document.
Adverse effects due to poor efficacy of a drug or medication error must also be reported to the authorities, according to the latest document.
The new rules will come into effect from 1 February 2025.
Denne historien er fra November 23, 2024-utgaven av Mint Mumbai.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Mint Mumbai
Mint Mumbai
Investors expect AI use to soar. That’s not happening
On November 20th American statisticians released the results of a survey. Buried in the data is a trend with implications for trillions of dollars of spending.
4 mins
November 28, 2025
Mint Mumbai
360 One, Steadview, others to invest in Wakefit ahead of IPO
A clutch of firms, including 360 One, Steadview Capital, WhiteOak Capital and Info Edge, is expected to invest in home-furnishings brand Wakefit Innovations Ltd just ahead of its initial public offering (IPO) next month, three people familiar with the matter said.
3 mins
November 28, 2025
Mint Mumbai
I-T dept to nudge taxpayers to declare foreign wealth
The department was able to collect 30,000 crore disclosed in the previous Nudge drive
2 mins
November 28, 2025
Mint Mumbai
Catamaran to boost manufacturing bets
Catamaran is focused on a few areas in manufacturing, such as aerospace
2 mins
November 28, 2025
Mint Mumbai
India, UAE review trade agreement to ease market access
Officials of India and the United Arab Emirates (UAE) met on Thursday to review how the Comprehensive Economic Partnership Agreement (CEPA) is working, and remove frictions that may be impeding trade between the two nations.
1 mins
November 28, 2025
Mint Mumbai
Beyond the stock slump-Kaynes' $1 bn aim is just the start
Shares of Kaynes Technology India Ltd have fallen about 25% from their peak of 7,705 in October, amid a management reshuffle and the expiry of the lock-in period for pre-IPO shareholders.
1 mins
November 28, 2025
Mint Mumbai
How Omnicom’s IPG buy will change Indian advertising
Two of the advertising world’s Big Four holding companies—Interpublic Group and Omnicom—officially merged this week.
2 mins
November 28, 2025
Mint Mumbai
Why TCS is walking a tightrope
Tata Consultancy Services Ltd recently outlined an ambitious multi-year $6-7 billion investment plan to build artificial intelligence (AI)-focused data centres and is already making progress in that area.
2 mins
November 28, 2025
Mint Mumbai
It's a multi-horse Street race now as Smids muscle in
For years, India’s stock market ran on the shoulders of a few giants. Not anymore.
3 mins
November 28, 2025
Mint Mumbai
Telecom firms flag hurdles in data privacy compliance
Operators need to comply with the data protection norms within 12-18 months
1 mins
November 28, 2025
Listen
Translate
Change font size